3D4K exoscope in epilepsy surgery: a seminal experience

Acta Neurochir (Wien). 2023 Dec;165(12):3921-3925. doi: 10.1007/s00701-023-05885-z. Epub 2023 Nov 10.

Abstract

Background and objectives: To report the progressive introduction of the exoscope (EX) from surface lesionectomy to antero-mesial temporal lobectomy (AMTL) in an epilepsy surgery practice.

Methods: We describe a population of ten consecutive patients undergoing EX surgery, with a minimum follow-up of 6 months, that was compared to a similar population of patients referred to operative microscopic surgery (OM).

Results: All surgeries were performed with the use of EX or OM alone. Transient neurological complications for surgery in eloquent regions were recorded in one patient for each population. Nine and seven patients undergoing, respectively, EX and OM surgery resulted in Engel class Ia (90% vs. 70%). The mean duration of EX and OM surgery resulted in 265.5 and 237.9 min, respectively, with a mean of 308.3 and 253.3 min for AMTL cases, respectively.

Conclusions: This preliminary study revealed that ORBEYE EX can be safe and effective in different types of epilepsy surgeries. The transition from OM to EX is fast, even though it is slower for the more challenging mesial temporal structure removal. Ergonomic and operative team interaction is improved by the use of EX. Our data need to be confirmed by larger studies.

Keywords: Drug-resistant epilepsy; Exoscope; Lesionectomy; Temporal lobectomy.

MeSH terms

  • Anterior Temporal Lobectomy
  • Epilepsy* / surgery
  • Epilepsy, Temporal Lobe* / surgery
  • Humans
  • Psychosurgery*
  • Retrospective Studies
  • Treatment Outcome